Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population

Published:2022-08 Issue:8 Volume:31 Page:1085-1092
ISSN:1443-9506
Container-title:Heart, Lung and Circulation
language:en
Short-container-title:Heart, Lung and Circulation

Author:

Hou Mingxi^ORCID,Hyun Karice^ORCID,Chew Derek P.^ORCID,Kritharides Leonard^ORCID,Amos David,Brieger David^ORCID

Funder

Merck Sharp and Dohme

AstraZeneca

National Health and Medical Research Council

Sanofi

Eli Lilly and Company

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine

Reference25 articles.

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002

2. Australian Medicines Handbook 2020 [online]. Adelaide: Australian Medicines Handbook Pty Ltd; 2020. Blood and Electrolytes: P2Y12 antagonists.

3. Effects of Clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation (CURE);Yusuf;N Engl J Med,2001

4. Addition of Clopidogrel to aspirin in 45,852 patients with acute myocardial infarction (COMMIT): randomised placebo-controlled trial;Chen;Lancet,2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS study;European Heart Journal: Acute Cardiovascular Care;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP